Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer
A University of Wisconsin–Madison trial is investigating the cognitive impact of neoadjuvant chemotherapy in patients with ovarian cancer.
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer [Phase 3]
An ongoing Phase 3 trial evaluates the PARP inhibitor olaparib, alone or with bevacizumab, for patients with ovarian, fallopian tube, or pri…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Living WELL: A Web-Based Program for Ovarian Cancer Survivors [NA]
This entry reports on Living WELL, a web-based program for ovarian cancer survivors, sponsored by Susan Lutgendorf, which is currently activ…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: EARLY Study: Evaluating the Specificity and Feasibility of the EARLY Biomarker Panel for Ovarian Cancer Detection [NA]
The EARLY Study is evaluating the specificity and feasibility of a biomarker panel for early detection of ovarian cancer and is currently re…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy [NA]
A clinical trial is evaluating alternate-day fasting after surgery for patients undergoing chemotherapy for ovarian and endometrial (uterine…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies [Phase 1, Phase 2]
AZD8205 is being studied in a Phase I/IIa trial as a single agent or in combination for advanced/metastatic solid tumors. Recruitment is ong…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion [Phase 2]
Phase 2 trial evaluating APL-2 with pembrolizumab versus APL-2 with pembrolizumab plus bevacizumab versus bevacizumab alone for recurrent ov…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: GYNecologic Cancer-Related COGnitive Impairment [NA]
This clinical trial update indicates completion of a study on gynecologic cancer-related cognitive impairment. The study enrolled patients w…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors [Phase 1]
Open-label Phase 1 study evaluating BL-M07D1 in HER2-expressing malignant solid tumors, with recruitment across several tumor types includin…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations [Phase 1, Phase 2]
Phase 1/2 trial of TER-2013 in solid tumors harboring AKT/PI3K/PTEN alterations is currently recruiting to assess safety and preliminary eff…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 first-in-human study of IPH5301, an anti-CD73 antibody, given alone or with chemotherapy and trastuzumab, in patients with advance…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Prognostic and Predictive Biomarkers in Ovarian Cancers [NA]
A clinical trial update focusing on prognostic and predictive biomarkers in ovarian cancer; the study is currently recruiting and does not r…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients [Phase 1]
Phase 1 clinical trial evaluating fecal microbiota transplantation for immune-checkpoint inhibitor–induced diarrhea or colitis in patients w…
-
EMA approval · 2026-03-19EMA Authorised: Lynparza (olaparib) — AstraZeneca AB
The EMA authorised Lynparza (olaparib) for multiple cancers in the European Union. Indications include ovarian cancer, breast cancer, pancre…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Prehabilitation in Gynaecological Cancer Patients [Phase 3]
This is an update on a Phase 3 clinical trial evaluating prehabilitation in gynecologic cancer patients (ovarian and endometrial cancer) tha…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal Chemotherapy [Phase 2]
Phase 2 trial completed to assess feasibility and quality of life of a second-look laparoscopy with hyperthermic intraperitoneal chemotherap…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) [Phase 2]
AstraZeneca's Dato-DXd is being studied as a single agent and in combination with other anti-cancer drugs in an ongoing Phase 2 trial for ad…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01) [Phase 3]
A Phase 3 study (BEHOLD-Ovarian01) is investigating GSK5733584 versus chemotherapy in platinum-resistant ovarian cancer; the trial is not ye…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Combination Therapy for Recurrent Ovarian Cancer [Phase 1, Phase 2]
A combination therapy trial for recurrent ovarian cancer is currently recruiting in Phase 1 and Phase 2.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Observational, Bi-directional (Prospective and Retrospective) Study for Patients With Newly Diagnosed Ovarian Cancer Stages IA to IVB, or Persistent or Recurrent Disease From January 2021; Irrespective of Histology
An observational bi-directional study (prospective and retrospective) enrolling patients with newly diagnosed ovarian cancer (stages IA-IVB)…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT [Phase 1, Phase 2]
This record summarizes ongoing Phase 1 and Phase 2 clinical trials evaluating prehabilitation strategies for ovarian cancer (including epith…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Clinical trial update on paclitaxel therapeutic drug monitoring in cancer patients; the study is currently suspended.
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 study evaluating the combination of Azenosertib (ZN-c3) and Niraparib in pl…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Radical Fimbriectomy for Young BRCA Mutation Carriers [NA]
This clinical trial update describes radical fimbriectomy as a preventive surgical option for young carriers of BRCA1 or BRCA2 mutations, wi…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating dual-targeting CAR-NK cells against MSLN, FRα, and MUC16 for recurrent epithelial ovarian cancer, primar…